Condition
Malignant Neoplasm of Liver
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by 68gaxh06
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Early Phase 1 (2)
Trial Status
Recruiting1
Not Yet Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
NCT07352345Early Phase 1Not Yet RecruitingPrimary
Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma
NCT06383520Early Phase 1RecruitingPrimary
Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular Carcinoma
Showing all 2 trials
Research Network
Common Treatments
- 68gaxh061
- 68gaagpc3scfvfab1
Active Sponsors
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
Top Investigators
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology